|
|
![]() |
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 18 October 2005
doi: 10.1242/jcs.02618
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
2 INSERM U589, Institut Louis Bugnard, 31403 Toulouse, France
3 Orthopaedic Research Laboratories, University of Washington, Seattle, WA 98195, USA
4 Department of Pediatrics, UCLA School of Medicine, CA 90095, USA
* Author for correspondence (e-mail: william.wilcox{at}cshs.org)
Accepted 8 August 2005
Overexpression of C-natriuretic peptide (CNP) in cartilage partially rescues achondroplasia in the mouse. Here, we studied the interaction of fibroblast growth factor (FGF) and CNP signaling in chondrocytes. CNP antagonized FGF2-induced growth arrest of rat chondrosarcoma (RCS) chondrocytes by inhibition of the Erk mitogen activated protein kinase pathway. This effect of CNP was protein kinase G-dependent and was mimicked by the cGMP analog pCPT-cGMP. FGF2-mediated activation of both MEK and Raf-1 but not Ras or FRS2 was abolished by CNP demonstrating that CNP blocks the Erk pathway at the level of Raf-1. CNP also counteracted the FGF2-mediated degradation of RCS extracellular matrix. CNP partially antagonized FGF2-induced expression, release and activation of several matrix-remodeling molecules including matrix metalloproteinase 2 (MMP2), MMP3, MMP9, MMP10 and MMP13. In addition, CNP compensated for FGF2-mediated matrix loss by upregulation of matrix production independent of its interference with FGF signaling. We conclude that CNP utilizes both direct and indirect ways to counteract the effects of FGF signaling in a chondrocyte environment.
Key words: Fibroblast growth factor, C-natriuretic peptide, Mitogen-activated protein kinase, Growth arrest, Extracellular Matrix, Chondrocyte
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
T. Matsushita, W. R. Wilcox, Y. Y. Chan, A. Kawanami, H. Bukulmez, G. Balmes, P. Krejci, P. B. Mekikian, K. Otani, I. Yamaura, et al. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway Hum. Mol. Genet., January 15, 2009; 18(2): 227 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Krejci, L. Salazar, H. S. Goodridge, T. A. Kashiwada, M. J. Schibler, P. Jelinkova, L. M. Thompson, and W. R. Wilcox STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes J. Cell Sci., February 1, 2008; 121(3): 272 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Moffatt, G. Thomas, K. Sellin, M.-C. Bessette, F. Lafreniere, O. Akhouayri, R. St-Arnaud, and C. Lanctot Osteocrin Is a Specific Ligand of the Natriuretic Peptide Clearance Receptor That Modulates Bone Growth J. Biol. Chem., December 14, 2007; 282(50): 36454 - 36462. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Krejci, B. Masri, L. Salazar, C. Farrington-Rock, H. Prats, L. M. Thompson, and W. R. Wilcox Bisindolylmaleimide I Suppresses Fibroblast Growth Factor-mediated Activation of Erk MAP Kinase in Chondrocytes by Preventing Shp2 Association with the Frs2 and Gab1 Adaptor Proteins J. Biol. Chem., February 2, 2007; 282(5): 2929 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Karakiulakis, E. Papakonstantinou, A. J. Aletras, M. Tamm, and M. Roth Cell Type-specific Effect of Hypoxia and Platelet-derived Growth Factor-BB on Extracellular Matrix Turnover and Its Consequences for Lung Remodeling J. Biol. Chem., January 12, 2007; 282(2): 908 - 915. [Abstract] [Full Text] [PDF] |
||||